Prognostic value of Musashi-1 in gliomas

Dahlrot, Rikke H.; Hansen, Steinbjørn; Herrstedt, Jørn; Schrøder, Henrik D.; Hjelmborg, Jacob; Kristensen, Bjarne W.
December 2013
Journal of Neuro-Oncology;Dec2013, Vol. 115 Issue 3, p453
Academic Journal
The aim of this study was to investigate the prognostic value of the RNA-binding protein Musashi-1 in adult patients with primary gliomas. Musashi-1 has been suggested to be a cancer stem cell-related marker in gliomas, and high levels of Musashi-1 have been associated with high tumor grades and hence poor prognosis. Samples of 241 gliomas diagnosed between 2005 and 2009 were stained with an anti-Musashi-1 antibody using a fluorescent staining protocol followed by automated image acquisition and processing. Musashi-1 area fraction and intensity in cytoplasm and in nuclei were quantified by systematic random sampling in 2 % of the vital tumor area. In WHO grade III tumors high levels of Musashi-1 were associated with poor survival in multivariate analysis (HR 3.39, p = 0.02). We identified a sub-population of glioblastoma (GBM) patients with high levels of Musashi-1 and a superior prognosis (HR 0.65, p = 0.038). In addition patients with high levels of Musashi-1 benefitted most from post-surgical treatment, indicating that Musashi-1 may be a predictive marker in GBMs. In conclusion, our results suggest that high levels of Musashi-1 are associated with poor survival in patients with WHO grade III tumors and that Musashi-1 may be a predictive marker in GBMs, although further validation is needed. We find the combination of immunofluorescence and automated quantitation to be a feasible, robust, and reproducible approach for quantitative biomarker studies.


Related Articles

  • ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion. Zhang, Wenlong; Liu, Yanwei; Hu, Huimin; Huang, Hua; Bao, Zhaoshi; Yang, Pei; Wang, Yinyan; You, Gan; Yan, Wei; Jiang, Tao; Wang, Jiangfei; Zhang, Wei // PLoS ONE;11/17/2015, Vol. 10 Issue 11, p1 

    Aldehyde dehydrogenases (ALDH) is a family of enzymes including 19 members. For now, ALDH activity had been wildly used as a marker of cancer stem cells (CSCs). But biological functions of relevant isoforms and their clinical applications are still controversial. Here, we investigate the...

  • Inhibition of Fatty Acid Synthase Decreases Expression of Stemness Markers in Glioma Stem Cells. Yasumoto, Yuki; Miyazaki, Hirofumi; Vaidyan, Linda Koshy; Kagawa, Yoshiteru; Ebrahimi, Majid; Yamamoto, Yui; Ogata, Masaki; Katsuyama, Yu; Sadahiro, Hirokazu; Suzuki, Michiyasu; Owada, Yuji // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    Cellular metabolic changes, especially to lipid metabolism, have recently been recognized as a hallmark of various cancer cells. However, little is known about the significance of cellular lipid metabolism in the regulation of biological activity of glioma stem cells (GSCs). In this study, we...

  • Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients. Byung Ho Kong; Ju HyungMoon; Yong-Min Huh; Jin-Kyoung Shim; Ji-Hyun Lee; Eui-Hyun Kim; Jong Hee Chang; Dong-Seok Kim; Yong-Kil Hong; Sun Ho Kim; Su-Jae Lee; Seok-Gu Kang // Stem Cells International;2014, p1 

    Cancer stem cells (CSCs) have been reported to be critical in the initiation, maintenance, and progression of cancers. The expression of stem cell markers, such as podoplanin (PDPN), CD133, and nestin, may have been correlated with malignant progression. However, the effects of CSCs and stem...

  • Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer. Su, Shasha; Hong, Feng; Liang, Yanling; Zhou, Jieqiong; Liang, Yan; Chen, Kequan; Wang, Xinying; Wang, Zhongqiu; Wang, Zhiqing; Chang, Cassie; Han, Weihua; Gong, Wei; Qin, Haitao; Jiang, Bo; Xiong, Huabao; Peng, Liang // PLoS ONE;11/24/2015, Vol. 10 Issue 11, p1 

    Objective: Leucine-rich-repeat-containing G-protein-coupled receptor 5 (lgr5) is a candidate marker for colorectal cancer stem cells (CSC). In the current study, we investigated the methylation status within thelgr5 promoter and evaluated its relationship with CSC differentiation, prognosis for...

  • NF-κB signaling in cancer stem cells: a promising therapeutic target? Vazquez-Santillan, K.; Melendez-Zajgla, J.; Jimenez-Hernandez, L.; Martínez-Ruiz, G.; Maldonado, V. // Cellular Oncology (2211-3428);Oct2015, Vol. 38 Issue 5, p327 

    Background: Cancer stem cells (CSCs) are regulated by several signaling pathways that ultimately control their maintenance and expansion. NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) forms a protein complex that controls DNA transcription and, as such, plays an...

  • Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Zhang, S; Mercado-Uribe, I; Xing, Z; Sun, B; Kuang, J; Liu, J // Oncogene;1/2/2014, Vol. 33 Issue 1, p116 

    Polyploid giant cancer cells (PGCCs) have been observed by pathologists for over a century. PGCCs contribute to solid tumor heterogeneity, but their functions are largely undefined. Little attention has been given to these cells, largely because PGCCs have been generally thought to originate...

  • Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells. Yamashita, Taro; Kaneko, Shuichi // Journal of Gastroenterology;Jul2014, Vol. 49 Issue 7, p1105 

    Hepatocellular carcinoma (HCC) is one of the world's most aggressive diseases and carries a poor prognosis for patients. Recent evidence suggests that HCC is organized by cancer stem cells (CSCs), which are a subset of cells with stem cell-like features. CSCs are considered a pivotal target for...

  • ON THE CASE. Pawar, Rahul V. // Radiology Today;Jun2012, Vol. 13 Issue 6, p10 

    The article presents a case study of a 47-year-old woman diagnosed with low-grade glioma (LGG) after undergoing periodic surveillance imaging for a focal left parietal lobe lesion. It mentions the relevance of differentiating between LGG and high-grade glioma (HGG) as the treatment differs....

  • Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Cao, L; Shao, M; Schilder, J; Guise, T; Mohammad, K S; Matei, D // Oncogene;5/17/2012, Vol. 31 Issue 20, p2521 

    Tissue transglutaminase (TG2), an enzyme involved in cell proliferation, differentiation and apoptosis is overexpressed in ovarian carcinomas, where it modulates epithelial-to-mesenchymal transition (EMT) and promotes metastasis. Its regulation in ovarian cancer (OC) remains unexplored. Here, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics